| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |